The Race to Find the Tangier Disease Gene

For this article, Brendan A. Maher interviewed Michael R. Hayden, director and senior scientist, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Canada; Stephan Rust, cholesterol metabolism group leader at the Institut für Arterioskleroseforschung an der Westfälischen Wilhelms-Universistät; and Gerd Schmitz, a physician and director of the Institut for Clinical Chemistry and Laboratory Medicine, University Hospital, Regensburg. Data from the Web of

Written byBrendan Maher
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

One of Tangier's most striking characteristics is the dramatic deficiency of high-density lipoprotein (HDL)--the so-called good cholesterol that is believed to transport excessive cholesterol from the bloodstream and transfer it to the liver where it can be expelled. The disease--also characterized by enlarged liver and spleen, peripheral neuropathy, lipid deposits in various body parts, and premature coronary artery disease--was seen as a perfect dysfunctional model for the elusive molecular basis of reverse cholesterol transport. Further, the connection with coronary artery disease (CAD), and correlation between low HDL levels and risk for CAD meant to researchers that a better understanding of Tangier could aid in fighting heart disease, a leading killer in the civilized world.

In the late 1990s, as new methods and advanced technologies in genetics became available, researchers broke into the final stretch. A linkage study mapped the gene to 9q31 in 19982 and in June of that year, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Conceptual cartoon image of gene editing technology

Exploring the State of the Art in Gene Editing Techniques

Bio-Rad
Conceptual image of a doctor holding a brain puzzle, representing Alzheimer's disease diagnosis.

Simplifying Early Alzheimer’s Disease Diagnosis with Blood Testing

fujirebio logo

Products

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS

The Scientist Placeholder Image

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

OGT logo

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel